Department of Medical Laboratory Technologies, Alnoor University, Mosul, Iraq.
Department of Public Health, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Turkiye Parazitol Derg. 2024 Jun 30;48(2):89-95. doi: 10.4274/tpd.galenos.2024.64326.
This research aims to update knowledge on the regional and national sickness burden attributable to cystic echinococcosis (CE) from 1990 to 2019, as well as epidemiology and disease control, with a particular emphasis on the People's Central Asian Regions.
We calculated the morbidity, mortality, and disability-adjusted life years at the global, regional, and national levels for CE in all central Asian countries from 1990 to 2019, and we analyzed the association between GDP per capita and the disease burden of CE.
In 2019, the three greatest numbers of CE cases were recorded in Kazakhstan [23986; 95% uncertainty interval (UI); 19796; 28908]; Uzbekistan (41079; 18351; 76048); and Tajikistan (10887; 4891; 20170) among all 9 countries. The three countries with the greatest ASIR of CE were estimated to be Kazakhstan (127.56; 95% UI: 105.34-153.8), Uzbekistan (123.53; 95% UI: 58.65-219.16), and Tajikistan (121.88; 58.57-213.93). Kyrgyzstan, Tajikistan, and Uzbekistan had the biggest increases (125%, 97%, and 83%, respectively) in the number of incident cases of CE, whereas Georgia, Kazakhstan, and Armenia saw the largest decreases (45%, 8%, and 3%, respectively).
To reduce the illness burden caused by CE, our findings may help public health professionals and policymakers design cost-benefit initiatives. To lessen the impact of CE on society, it is suggested that more money be given to the region's most endemic nations. Echinococcosis, cystic, negative health effects, life-years lost due to disability, rate of occurrence as a function of age, rate of death as a function of age.
本研究旨在更新 1990 年至 2019 年期间囊性包虫病（CE）在区域和国家疾病负担方面的知识，以及流行病学和疾病控制方面的知识，重点关注中亚各国。
我们计算了所有中亚国家 1990 年至 2019 年期间全球、区域和国家各级的 CE 发病率、死亡率和残疾调整生命年（DALY），并分析了人均 GDP 与 CE 疾病负担之间的关系。
2019 年，哈萨克斯坦（23986；95%不确定区间[UI]；19796；28908）、乌兹别克斯坦（41079；18351；76048）和塔吉克斯坦（10887；4891；20170）报告的 CE 病例数位居所有 9 个国家之首。CE 发病率最高的三个国家估计为哈萨克斯坦（127.56；95% UI：105.34-153.8）、乌兹别克斯坦（123.53；95% UI：58.65-219.16）和塔吉克斯坦（121.88；58.57-213.93）。吉尔吉斯斯坦、塔吉克斯坦和乌兹别克斯坦的 CE 新发病例数增幅最大（分别为 125%、97%和 83%），而格鲁吉亚、哈萨克斯坦和亚美尼亚的降幅最大（分别为 45%、8%和 3%）。
为了降低 CE 带来的疾病负担，我们的研究结果可能有助于公共卫生专业人员和政策制定者制定成本效益措施。为了减轻 CE 对社会的影响，建议向该地区受影响最严重的国家提供更多资金。包虫病，囊性，负面健康影响，残疾导致的生命损失年，发病率随年龄变化，死亡率随年龄变化。
